Skip to main content
SEOULEAGUER CO., LTD. logo

SEOULEAGUER CO., LTD. — Investor Relations & Filings

Ticker · 043710 ISIN · KR7043710003 KO Human health and social work activities
Filings indexed 295 across all filing types
Latest filing 2020-03-17 Director's Dealing
Country KR South Korea
Listing KO 043710

About SEOULEAGUER CO., LTD.

http://www.seouleaguer.co.kr

SEOULEAGUER CO., LTD. is a healthcare company specializing in the medical beauty sector. The company's core business involves the wholesale and retail distribution of pharmaceuticals, cosmetics, botulinum toxins, and dermal fillers. Additionally, Seouleaguer operates as a Management Service Organization (MSO), providing comprehensive management support services to hospitals and clinics. This dual focus on product distribution and operational support establishes it as a medical beauty care platform for healthcare providers.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when insiders or major shareholders change their holdings in a listed company. This falls under the category of 'Director's Dealing' (DIRS) as it reports the personal share transactions and ownership status of company insiders and major shareholders.
2020-03-17 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for Seouleaguer Co., Ltd. It contains the meeting agenda, details on voting procedures, and management information (such as board activity and financial statements) to be presented to shareholders. This document is a standard proxy statement/notice for an upcoming AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-03-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Correction Report). It details the cancellation of previously granted stock options for directors and executives. This type of filing, which concerns changes to capital structure and equity-based compensation, falls under the category of 'Share Issue/Capital Change' (SHA) as it relates to the issuance or modification of equity instruments.
2020-03-16 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing from a Korean company (Seoul Leaguer) regarding the cancellation of previously granted stock options (주식매수선택권 부여 취소). It follows the standard format for a 'Correction Report' (정정신고) filed with the Financial Services Commission/Korea Exchange. Since this document details changes to equity-based compensation and capital structure (stock options), and does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Remuneration Information' (which is for executive compensation reports), it is best classified as a general regulatory filing.
2020-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (Seoul-Liguer) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. It provides a summary table of financial performance and reasons for the variance, which fits the 'Earnings Release' (ER) category as it serves as an initial announcement of financial results/highlights before the full audit is finalized. FY 2019
2020-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Seoulriger. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, appointment of auditors, and director remuneration. This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the meeting and the items to be voted upon.
2020-03-13 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.